|
Age, median (IQR), months
|
11.0 (6.0–21.5)
|
14.5 (9.7–23.0)
|
0.133
|
|
Male, n (%)
|
42 (73.7)
|
43 (79.6)
|
0.460
|
|
Breastfeeding, n (%)
|
35 (61.4)
|
30 (55.6)
|
0.532
|
|
≥ 2 children in household, n (%)
|
34 (59.6)
|
37 (68.5)
|
0.331
|
|
Length of hospitalization, median (IQR), days
|
11.0 (9.0–13.2)
|
11.0 (8.0–13.0)
|
0.001
|
|
Peripheral blood eosinophils, median (IQR), %
|
0.7 (0.3–1.3)
|
0.9 (0.2–2.3)
|
0.385
|
|
IgE, median (IQR), IU/mL
|
77.1 (11.1–132.2)
|
46.4 (9.2–160.6)
|
0.833
|
|
Subpopulation of lymphocytes, median (IQR), %
|
|
CD19+CD23+
|
13.6 (10.5–19.4)
|
13.3 (9.9–18.1)
|
0.383
|
|
CD3+
|
61.3 (52.4–70.9)
|
65.1 (52.6–70.3)
|
0.626
|
|
CD3+ CD4+
|
35.0 (26.9–39.7)
|
35.3 (31.4–45.1)
|
0.063
|
|
CD3+CD8+
|
24.3 (17.6–28.6)
|
18.5 (15.6–26.2)
|
0.023
|
|
CD3−CD16+CD56+
|
9.6 (6.3–13.1)
|
8.9 (5.4–11.7)
|
0.647
|
|
CD3−CD19+
|
24.6 (18.2–31.1)
|
21.9 (17.6–30.6)
|
0.482
|
|
Humoral immunity, median (IQR), g/L
|
|
Total IgA
|
0.43 (0.16–0.66)
|
0.32 (0.16–0.59)
|
0.273
|
|
Total IgM
|
0.89 (0.68–1.46)
|
0.9 (0.63–1.36)
|
0.700
|
|
Total IgG
|
6.09 (4.91–7.93)
|
5.73 (4.25–7.92)
|
0.254
|
|
Cytology of BALF, median (IQR), %
|
|
Macrophages
|
50.0 (13.5–87.0)
|
54.0 (24.5–82.5)
|
0.554
|
|
Neutrophils
|
38.0 (10.0–77.5)
|
36.5 (12.0–62.0)
|
0.437
|
|
Lymphocytes
|
4.0 (2.0–9.5)
|
5.0 (2.0–6.7)
|
0.954
|
|
Eosinophils
|
0.0 (0.0–2.0)
|
0.5 (0.0–6.0)
|
0.027
|
